The drug compounds Cicloflavin A+ Zanton L could be the cure of cancer.
Clara Alba Martí1
1Institut Puig de la Creu
ABSTRACT
An ex periment has been made with the purpose of investigating if the following drug compounds are suitable for the cure of
cancer: Cicloflavin A and Zanton L. Moreover, we have done an analysis of the mitotic index in order to test the efficiency of the
drug compounds. As a result, differences have been exposed on the effectiveness of the treatments. The results have allowed us
to conclude that there are considerable changes in the efficiency of the different treatments.
Key words: Cancer, Mitosis, Cicloflavin A, Zanton L, Mitotic index, Treatment.
INTRODUCTION
Mitosis is a process of nucleus division, in which
one cell divides into two genetically identical
daughter cells. It is a fundamental process for
growth, development, and repair in
multicellular organisms. During mitosis, the
DNA in the parent cell replicates, and then the
replicated chromosomes are evenly distributed
into the two daughter cells, ensuring that each
new cell receives a complete set of genetic
information.
Cancer is the development of abnormal cells
which divide uncontrollably throughout a
particular zone of the organism, having the
ability to infiltrate through the bloodstream
and being able to spread to other parts of the
body.
When mitosis occurs infinitely, produces
uncontrolled cell division, this mass of cells
replicate itself to make new cells that are also
out of control. These ones are cancerous cells.
They can form tumours that damage the
surrounding tissues.
The aim of this scientific research is to
investigate whether cancer can be treated by
using two drug compounds (Cicloflavin A and
Zanton L) that could reduce the mitotic index,
which is a proportion between the cells in
interphase and the ones in the process of
nucleus cell division (mitosis).
For these reasons, we think that maybe these
drug compounds could be used as a treatment
for reducing the mitotic index and therefore as
a possible cure for cancer.
Picture explaining cancer, Oncology department,
PantaiHospital,KualaLumpur
MATERIAL AND METHODS
Two mice with cancer disease have been taken
to verify our initial goal. They have been
subjected to an experiment done with the drug
compounds Cicloflavin A and Zanton L.
The procedure for carrying out the experiment
has several parts: firstly, a sample with a bunch
of tumoral cells from the mice has been
extracted and analysed with the microscope.
Secondly, one of them has been provided with
10 U of Cicloflavin A in a period of time of one
month. We have done the same with the other
mouse, but with a slight variation on the drug
compound, we have added the compound
Zanton L. Lastly, the biopsy has been made
again at the same tumoral area as in the pre-
test and also observed through the microscope.
In both treatments, almost all the variables
have been the same: temperature (25ºC), diet,
dose (10U) and time (one month). The only
